Connect Biopharma Holdings (CNTB) Leases (2023 - 2025)
Connect Biopharma Holdings (CNTB) has disclosed Leases for 3 consecutive years, with $647000.0 as the latest value for Q4 2025.
- Quarterly Leases rose 242.33% to $647000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $647000.0 through Dec 2025, up 242.33% year-over-year, with the annual reading at $647000.0 for FY2025, 242.33% up from the prior year.
- Leases hit $647000.0 in Q4 2025 for Connect Biopharma Holdings, down from $737000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $900000.0 in Q1 2025 to a low of $189000.0 in Q4 2024.
- Historically, Leases has averaged $626666.7 across 3 years, with a median of $692000.0 in 2025.
- Biggest five-year swings in Leases: tumbled 59.09% in 2024 and later surged 242.33% in 2025.
- Year by year, Leases stood at $462000.0 in 2023, then plummeted by 59.09% to $189000.0 in 2024, then soared by 242.33% to $647000.0 in 2025.
- Business Quant data shows Leases for CNTB at $647000.0 in Q4 2025, $737000.0 in Q3 2025, and $825000.0 in Q2 2025.